Medscape in the Clinic: Sequencing and Rechallenging Oral TKI Therapies in Metastatic CRC

Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase inhibitor (TKI) therapies in a manner that considers the patient’s status, strategically allows for an increased time on therapy, and optimizes the mechanism of action of agents to the patient’s previous therapy response patterns.

Faculty
Marc Peeters, MD, PhD
Kanwal P. S. Raghav, MBBS, MD

This event is supported by an independent educational grant from Bayer

Видео Medscape in the Clinic: Sequencing and Rechallenging Oral TKI Therapies in Metastatic CRC канала Medscape